NeuroPace (NPCE) Tops Q2 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance

NeuroPace (NASDAQ: NPCE) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $18.3 million.

GUIDANCE:

NeuroPace sees FY2024 revenue of $76-78 million, versus the consensus of $75.9 million.

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c